Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

Study demonstrates clinical accuracy of Masimo's noninvasive, continuous hemoglobin monitoring technology

Study demonstrates clinical accuracy of Masimo's noninvasive, continuous hemoglobin monitoring technology

FDA grants CASMED 510(k) clearance for expanded labeling of FORE-SIGHT Absolute Tissue Oximeter

FDA grants CASMED 510(k) clearance for expanded labeling of FORE-SIGHT Absolute Tissue Oximeter

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec reimburses VIDAZA for treatment of blood cancer

First 6 months of exclusive breast feeding: Child health experts question recommendation

First 6 months of exclusive breast feeding: Child health experts question recommendation

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Entelos receives U.S. Patent for Predictive Toxicology for Biological Systems

Entelos receives U.S. Patent for Predictive Toxicology for Biological Systems

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Scientists identify prognostic biomarker to treat patients with HCV

Scientists identify prognostic biomarker to treat patients with HCV

Study shows adolescents who were breastfed at birth have stronger leg muscles

Study shows adolescents who were breastfed at birth have stronger leg muscles

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

First “saviour sibling” procedure successful

First “saviour sibling” procedure successful

Gold-coated liposomes could make chemotherapy more effective without harmful side effects

Gold-coated liposomes could make chemotherapy more effective without harmful side effects

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Pfizer's sublicensing of Tanaproget triggers $1 million upfront payment to Ligand

Pfizer's sublicensing of Tanaproget triggers $1 million upfront payment to Ligand

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.